Topic

Insurance Approval

A collection of 2899 issues

Getting Therakos CELLEX Photopheresis Covered by Humana in Illinois: Complete Guide to Prior Authorization and Appeals

Quick Answer: Therakos CELLEX photopheresis requires prior authorization from Humana for CTCL and steroid-refractory GVHD. Submit complete clinical documentation showing diagnosis, failed prior treatments, and specialist oversight through Humana's provider portal. If denied, you have 65 days to appeal, with Illinois offering external review within 30 days. Start
5 min read

Renewing Besponsa (Inotuzumab Ozogamicin) Approval with Cigna in Florida: Complete 2025 Guide

Quick Answer: Besponsa (inotuzumab ozogamicin) renewals with Cigna require updated clinical documentation showing continued medical necessity for CD22-positive ALL. Start your renewal 30-45 days before your current authorization expires. Submit through Cigna's provider portal or fax 1-866-873-8279 with recent labs, treatment response data, and hepatotoxicity monitoring results. In
5 min read

How to Get Alecensa (alectinib) Approved by Blue Cross Blue Shield Illinois: Complete Prior Authorization Guide

Quick Answer: Getting Alecensa Covered by BCBS Illinois Alecensa (alectinib) requires prior authorization from Blue Cross Blue Shield of Illinois for ALK-positive NSCLC. Your fastest path to approval: (1) Confirm ALK-positive test results are documented, (2) Submit PA request through Availity Essentials or provider portal with complete clinical documentation, (3)
6 min read

How to Get Orkambi (lumacaftor/ivacaftor) Covered by Cigna in California: Appeals Timeline and Documentation Guide

Answer Box: Getting Orkambi Covered by Cigna in California Fastest Path: Submit prior authorization with genetic test results showing F508del homozygosity, CF diagnosis documentation, and specialist prescription. If denied, file internal appeal within 180 days, then request California Independent Medical Review (IMR) through DMHC. Success rate for IMR appeals is
6 min read